FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze
|
|
|
- Juliana Sims
- 10 years ago
- Views:
Transcription
1 FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze BENEFITS AND PRICING Q: What benefits does Oral-Eze present? A: The Oral-Eze Oral Fluid Collector has a built-in indicator for determining when a sufficient quantity of oral fluid has been collected. This will reduce the number of tests that are reported as quantity insufficient (QNS) by the laboratory. Another benefit is that the oral fluid collector does not have a salty or citric taste. Q: I m accustomed to using Intercept and would like to continue ordering that product. Will Quest Diagnostics continue to support other oral fluid testing options? A: Quest Diagnostics is fully committed to our new product. As of January 1, 2012 we transitioned our clients to the Oral-Eze device and we are phasing out the supply of other devices. We realize that specimens collected on the old device will continue to make their way to the laboratory for a period of time, and while we will discontinue testing alternative oral fluid devices, we will give at least 60-day notice prior to this discontinuation. Q: What is the price of this new product? A: With a sample adequacy indicator, the Oral-Eze system will reduce the number of specimens with an insufficient volume for testing. This reduction will eliminate the need for the redundant purchase of devices, thereby saving our customers money. We are happy to bring you this improved product for the same fee that you currently pay. Q: Is there also a change in the testing technology that the lab uses? A: Yes. The testing technology that will now be used by our labs for oral fluid drug tests will enable faster throughput and highly reliable turnaround times. THE COLLECTION EXPERIENCE Q: How long does it take to collect an oral fluid sample with Oral-Eze? A: The Oral-Eze collection is complete when the indicator window turns blue. This typically occurs within 3-5 minutes. In our studies, 83% of donors provided an adequate sample in five minutes or less. With that said, every donor is different. As with all oral fluid collection systems, collectors should coach their donors regarding how best to provide an adequate sample volume. Before beginning the collection, instruct the donor to pool their saliva and then, once the Oral-Eze collector is in their mouth, to direct saliva towards the pad. Ask them to refrain from swallowing and talking, instead directing that saliva towards the device. Ensure that they keep the device in their mouth for the allotted time or until the indicator window turns blue. Q: What is the best practice for transferring the pad from the collector to the tube? A: Once the indicator window turns blue, instruct the donor to simply place their thumb on the ridges of the collector handle and gently slide forward to detach the pad into the collection tube. If the pad does not immediately detach into the tube, gently press the pad against the lip of the tube and gently withdraw the collector handle. If the pad is not sufficiently saturated with oral fluid, as indicated by a blue color in the indicator window, it may be more difficult to detach FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze 1
2 Q: What makes Oral-Eze taste better than the old device? A: The Oral-Eze collection pad is simply a cotton fiber filter paper. Unlike some other devices Oral- Eze has not been treated with any salty or citric chemicals. TRANSPORTATION Q: What is the turnaround time? A: Testing is performed the day the samples arrive at the laboratory and negative screening results are typically reported the same day. Positive results are confirmed, reviewed, and typically reported within 72 hours of receipt. Q: How do I get the specimen to the laboratory? A: The oral fluid specimen should be sent using the same mode of transportation Quest Diagnostics or overnight courier that you currently utilize. If you are new to oral fluid testing, your account representative will assist in determining the optimum mode of transportation. Q: Will the laboratory that processes my tests change? A: No. Our Lenexa, Kansas laboratory will continue to perform oral fluid drug tests. ADULTERATION Q: Can an oral fluid test be beaten? A: We have not found any adulterants that can beat the test at this time. Of course, donors may attempt to introduce something onto the pad or collection vial. This risk is minimized because every collection is directly and easily observed. Q: How does the laboratory determine if the specimen is valid? A: With every specimen, the laboratory performs an Albumin test. This test helps ensure that the specimen is saliva and that there is sufficient saliva to perform the drug testing. The Albumin test is a specimen validity test. Q: Why are you changing the test for specimen validity? A: With the change in testing technology for the drug tests, we utilize a different indicator of specimen validity. Albumin is an endogenous (i.e. naturally occurring) substance that is expected to be in all donor s oral fluid/saliva and serves as an excellent test for specimen validity. REGULATIONS Q: Is the Oral-Eze test FDA-cleared? A: Yes, both the Oral-Eze Oral Fluid Collection System and the drug tests using the Oral-Eze collection system are FDA-cleared. Q: Can the Oral-Eze test be used for Department of Transportation (DOT) testing? A: No, the DOT has not approved any oral fluid drug testing system at this time. Q What does FDA Clearance mean? A: The FDA has evaluated both performance data and labeling. An FDA cleared assay meets current standards for accuracy and reliability, including the importance of confirmatory testing when the results of the screening test are positive. Manufacturers of tests with FDA approval or clearance have provided the FDA with data to assure that their tests generate reliable results for the specimens being tested FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze 2
3 DETECTION/CUTOFFS Q: What drugs are tested with Oral-Eze A: The drugs tested for are the following: Amphetamines, Methamphetamines (including MDMA and its metabolite), Opiates (Codeine, Morphine, Hydrocodone, Hydromorphone, 6- monoacetylmorphine), Cocaine (Metabolite), THC, and Phencyclidine (PCP). Q: Can the Oral-Eze test detect Ecstasy? A: Yes, Ecstasy (MDMA) is reported under the Methamphetamines group. Q: Can the Oral-Eze test detect semi-synthetic opiates? A: Yes, in addition to codeine, morphine, and 6-monoacetylmorphine, the Oral-Eze Opiates test detects hydrocodone and hydromorphone. All five of these opiates are routinely reported if detected in the oral fluid specimen. Q: Can the Oral-Eze test detect oxycodone? A: No, the Oral-Eze test should not be used to detect oxycodone use. Q: How long are positive (non-negative) specimens retained by the laboratory? A: Non-Negative specimens are retained for a minimum of 12 months (the same as a non-negative urine specimen). Q: Will there be any changes in the drugs detected using the Oral-Eze or new testing technology? A: No. The test menu will remain unchanged. While there will be a reduction in the screening cutoff for amphetamine, the confirmation cutoff levels for amphetamine will remain the same and therefore we expect the positivity rate to be similar. Q: Why are the initial and confirmatory levels different than what I am used to seeing on my reports? A: The US Food and Drug Administration (FDA) has asked manufacturers of oral fluid testing systems to represent cutoffs in terms of the concentration of original ( neat ) oral fluid rather than in terms of the concentration in the collection tube after dilution with a buffer preservative. Consequently, all second generation testing systems submitted to the FDA for clearance will utilize this cutoff representation. The Oral-Eze Oral Fluid Collection System has a three-fold dilution of neat oral fluid with the buffer preservative solution in the collection tube, consequently the cutoffs for testing systems that utilize this Oral-Eze system are three times higher (e.g. opiates with the Intercept collection system have a 10 ng/ml cutoff and opiates with the Oral-Eze collection system have a 30 ng/ml cutoff). The manner in which the cutoff is expressed (neat versus diluted) is not expected to change detection or positivity rates. Q: Can I still get my reports using the old initial and confirmatory test levels? A: Unfortunately, no. Oral fluid drug tests that utilize second generation testing systems, cleared by the FDA at cutoffs expressed in terms of the original oral fluid, must be reported with their FDAcleared labeling. Q: Will the test levels be changing for the OraSure product? A: It is our understanding that OraSure has partnered with Roche Diagnostics in the development and manufacturing of a second generation laboratory testing system using the Intercept collector. These new FDA-cleared assays manufactured by Roche Diagnostics also express cutoffs in terms of original ( neat ) oral fluid FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze 3
4 Q: What are the cutoffs and analytes for the oral fluid drug test using the Oral-Eze Oral Fluid Collection System: A: DRUG CLASS INITIAL TEST CONFIRMATORY CONFIRMATORY LEVEL LEVEL LEVEL METHOD* AMPHETAMINE 150 ng/ml 120 ng/ml GC/MS METHAMPHETAMINES 120 ng/ml METHAMPHETAMINE 120 ng/ml GC/MS MDMA 120 ng/ml GC/MS MDA 120 ng/ml GC/MS COCAINE METABOLITES 15 ng/ml BENZOYLECGONINE 6 ng/ml GC/MS MARIJUANA 3 ng/ml 1.5 ng/ml GC/MS OPIATES 30 ng/ml MORPHINE 30 ng/ml GC/MS CODEINE 30 ng/ml GC/MS HYDROMORPHONE 30 ng/ml GC/MS HYDROCODONE 30 ng/ml GC/MS 6-MONOACETYLMORPHINE 3 ng/ml GC/MS PHENCYCLIDINE 3 ng/ml 1.5 ng/ml GC/MS GC/MS includes GC/MS/MS which may be used for some analytes. Q: How does the detection window for Oral-Eze compare with other methods such as urine? A: Just like traditional urine testing, the window of detection in oral fluid is different for each drug. Like urine drug testing, oral fluid drug testing detects recent drug use and may also identify very recent usage that may be missed by urine testing. For most drugs, the maximum window of detection in oral fluid is about one-to-two days. By contrast, urine testing detects drugs or their metabolites excreted in one of the body s waste systems and does detect some drugs for a slightly longer period (1 to 3 days). Moreover, oral fluid testing may detect drug use 1 to 2 hours after ingestion/use. Urine testing usually requires 2-6 hours to detect use after ingestion/use. Even with slightly different detection windows, the positive prevalence ( positivity ) rates for urine and oral fluid are quite similar. Q: How does the positivity rate for oral fluid compare with urine? A: Oral Fluid vs. Urine (January 2005 December 2011) Drug Category Oral Fluid (N~5.8MM) Urine (N~38MM) Overall 1 4.1% 4.3% Amphetamine % 0.49% Methamphetamines % 0.15% Cocaine (Metabolite) 0.74% 0.50% Marijuana/Metabolite 2.5% 2.2% Opiates % 0.37% Phencyclidine (PCP) 0.02% 0.02% Includes test results for other non-samhsa drugs such as barbiturates and benzodiazepines Urine: As a percentage of all tests for Amphetamines Oral Fluid: Includes methamphetamine and MDMA/analogues Urine: As a percentage of all tests for Amphetamines Oral Fluid: ~71% of tests include hydrocodone and hydromorphone Urine: ~9% of tests include hydrocodone and hydromorphone FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze 4
5 REPORTING Q: How are the results reported? A: As with all laboratory-based testing, results are recorded in the laboratory information system and reported to the client by confidential fax, direct interface, web reporting (QIS), printer, or voice response. Q: Will there by any change in how I receive my results? A: No. However, your results report will reflect the different screening cutoff for amphetamine and how cutoffs are represented. Q: Will there be any change in how I interpret the results? A: No. It will read the same. COLLECTION/SUPPLIES Q: Do I have to pay for the collection devices in advance? A: The cost structure for the Oral-Eze Oral Fluid Collection System will remain unchanged. You will be responsible for purchasing kits and testing separately. Q: Who manufactures the drug testing system that uses the Oral-Eze device? A: ThermoFisher is the manufacturer of both the Oral-Eze Oral Fluid Collection System and the testing reagents used by the laboratory. Q: Can I use my urine custody and control form? A: There is an alternative specimen custody and control that should be used. It is intended for laboratory based testing of oral fluid and hair specimens. Q: Can the test be run if I use the regular urine custody and control form by mistake or I have run out of the alternate custody and control form? A: Yes, but the tamper-evident tape on the urine custody and control form (CCF) is designed for the urine bottle and is too long for the oral fluid vial. Consequently, the urine CCF should only be used in an emergency situation. To use the urine custody and control form properly you should center the tamper-evident seal over the top of the oral fluid collection tube. Next, starting with the end that does not have the specimen ID number printed on the seal, wrap the seal down the side, around the bottom of the tube and back up the opposite side. The end of the seal that contains the specimen ID number must be visible. Otherwise, the specimen may be rejected if the laboratory cannot read the specimen ID number. Q: How do I collect a split specimen? A: Two oral fluid collectors (two oral fluid collection pads) are used collected either simultaneously or sequentially. If collected simultaneously, the donor should place one collector on each side of the mouth. After the specimen is collected on the swab, have them eject one pad in one plastic vial and the other pad in the other plastic vial. If collected sequentially, the second collector should be placed in the donor s mouth no more than two (2) minutes after the end of the collection of the first specimen. Q: Who collects the sample? A: One of the advantages of an oral fluid collection is that the donor controls his or her sample under direct visual supervision. The collector really is an observer and has a small role in the chain of custody - the process most often challenged by donors. If the donor wants to challenge the FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze 5
6 collection, the only person to challenge is him or herself. On average, an oral fluid collection with Oral-Eze takes just three to five (3-5) minutes. Q: What is the liquid in the vial? A: The liquid is a buffer, preservative solution that stabilizes the oral fluid sample and helps prevent the sample and drugs/metabolites from deteriorating during shipment to the laboratory or storage. Q: Will recent oral surgery (root canals, extraction s, etc.) or sutures make a difference? A: Neither will affect the collection; however, if sutures are located between the lower cheek and gum, it is better to collect the sample from the opposite side of the mouth. Q: When collecting an oral fluid specimen, I noticed a small amount of blood on the collection pad. Is this normal? A: Although this is not common, it may occur in some individuals and should not adversely affect the specimen collected. Q: How long is the specimen stable after it has been collected? A: As a part of the FDA-clearance process, the manufacturer has demonstrated that the specimen and any drugs in the specimen are stable for 21 days after collection. Non-Negative specimens tested by the laboratory are stable for at least 1 year when stored frozen. Q: What if the donor is taking medications and wants to write the names of the medications on the custody and control form? A: For privacy reasons, the names of medications that the donor may be taking must not be listed on the custody and control form. However, as a reminder, the donor may list them on the back -side of their copy of the form in the event the donor is contacted by a Medical Review Officer. Q: Isn t oral fluid a hazardous fluid? A: No. Because the testing methodology is not classified as a dental process, OSHA does not consider oral fluid a hazardous fluid. Q: Do I order Oral-Eze from Quest Diagnostics? A: Yes, you should order the Oral-Eze Oral fluid Collection System from Quest Diagnostics. You can order these supplies just the same as you would order the routine custody and controls forms and the urine collection kits. Q: What is the shelf life of the Oral-Eze Oral fluid Collection System? A: Up to 24 months. Typically, collection systems will be shipped with a minimum of 12 months remaining shelf-life. Q If I run out of the collection devices, can I use a different device? A No, the testing system used by a laboratory is matched to the collection device used to collect the oral fluid specimen. Q: What do I do with all the old Intercept kits I ve already purchased? A: We encourage you to exhaust your existing supply of Intercept. Quest Diagnostics will continue to process both devices for a period of time. However, when you place an order for new oral fluid collection supplies we will automatically transition you to the Oral-Eze product. Q: How do I order the new collection system? A: You can order the Oral-Eze Oral Fluid Collection System in the same manner that you presently order your supplies you can send an to [email protected], fax , or call FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze 6
7 Q: Will I need a new CCF form with Oral-Eze? A: No, however, the next time you order your CCF forms, you will notice the new Oral-Eze test order codes preprinted on the form. Q: How long are positive (non-negative) specimens retained by the laboratory? A: Non-Negative specimens are retained for a minimum of 12 months (the same as a non-negative urine specimen). Q: Is the pad safe to put in my mouth? A: Yes, the pad is a cotton-fiber filter paper that has not been treated with any salts or flavorings. Q: How should I orient my staff to the Oral-Eze collection system? A: Please visit the Employer Solutions web site at Oral-Eze.com to learn more, watch a collection demonstration video, and take our online training. Q: What are the supply order codes for Oral-Eze? A: Yes. The Oral-Eze supply order codes are: Oral-Eze Kit (collection system and specimen transportation bag) Oral-Eze Kit w/shipping supplies (collection system and specimen transportation bag, FedEx mailer, pre-printed airbill) Q: What do I receive when I order Oral-Eze Oral fluid Collection Systems? A: You will receive an Oral-Eze Oral fluid Collection System and a specimen transportation bag (i.e. chain-of-custody bag) for each Oral-Eze Collection System ordered. Custody and Control Forms must be ordered separately. If the specimens are shipped to the laboratory by overnight courier, airbills for shipping the specimen to your designated laboratory are included with each order of Oral-Eze Oral fluid Collection Systems. TECHNICAL Q: What methodology is used? A: A two-tiered testing process is used: A portion of the oral fluid sample is first screened using enzyme immunoassay (EIA), a proven reliable methodology for routine drug testing. Any samples that are presumptively positive in the screening process are then confirmed, utilizing another portion of the oral fluid sample, using either gas chromatography/mass spectrometry (GC/MS) or gas chromatography/mass spectrometry/mass spectrometry (GC/MS/MS) Q: Is EIA forensically defensible? A: Yes, the technology is well established and is the same technology that has long been used for screening for drugs of abuse in urine. Q: What is the difference between GC/MS and GC/MS/MS? A: GC/MS is the more traditional confirmation method for drugs of abuse testing. Both technologies produce a molecular fingerprint of the drug or compound being analyzed and provide definitive identification. GC/MS/MS, a newer technology also known as tandem MS, generally provides greater sensitivity which may be necessary for the analysis of alternative specimens. Q: From the laboratory perspective, what is different about the Oral-Eze product? A: One of the assays (amphetamine) has a lower screening cutoff level than Intercept, but the confirmation level remains the same. Albumin is used as the specimen validity test instead of IgG. A specific type of enzyme immunoassay (EIA), cloned enzyme donor immunoassay (CEDIA ), is used as the initial testing technology FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze 7
8 Q: What is the difference between EIA and ELISA? A: EIA is the more traditional enzyme immunoassay. The technology has been widely used for the analysis of drugs of abuse in urine. It is homogenous in nature meaning that the analysis is performed without any physical separation during the analysis, which enables faster throughput and improved turnaround times. ELISA is a heterogeneous process which requires several processing steps prior to reading the results. Newer EIA technologies, such as CEDIA, permit the detection of the lower concentrations of drugs found in oral fluid samples. Quest, Quest Diagnostics, any associated logos and all associated Quest Diagnostics registered and unregistered trademarks are the property of Quest Diagnostics. All third party marks and are the property of their respective owners Quest Diagnostics Incorporated. All rights reserved FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze 8
FREQUENTLY ASKED QUESTIONS Hair Testing
MRCH 2011 FREUENTLY SKED UESTIONS Hair Testing DRUGS & CUTOFFS TECHNICL EXPLNTIONS What testing methodology is used for hair tests? two-tiered testing process is used: 1) portion of the hair sample is
Practical Aspects of Drug Testing in Human Hair
Practical Aspects of Drug Testing in Human Hair Laboratory Perspective James A. Bourland, Ph.D., DABFT FOR INTERNAL USE ONLY. NOT FOR PRINT OR DISTRIBUTION Overview of Collection Process FOR INTERNAL USE
Pennsylvania Hospital & Surgery Center ADMINISTRATIVE POLICY MANUAL
Page 1 Issued: May 2003 Committee Approval: Human Resources Administrative Policy Review Committee: May 2004 May 2005 May 2007 June 2008 Attachment(s): Consent Acknowledgement Form Related Policies: POLICY
Hillsborough Community College - Ybor City Campus 1025C Laboratory Exercise 9: Testing Urine for the Presence of Drugs Introduction
Hillsborough Community College - Ybor City Campus 1025C Laboratory Exercise 9: Testing Urine for the Presence of Drugs Introduction Drug testing beyond the health care and criminal justice systems has
Technical Note. Introduction. Edward J. Cone. Lance Presley, Michael Lehrer, William Seiter, and Melissa Smith
Technical Note Oral Fluid Testing for Drugs of Abuse: Positive Prevalence Rates by Intercept Immunoassay Screening and GC MS MS Confirmation and Suggested Cutoff Concentrations * Edward J. Cone ConeChem
Collection Instructions for ARUP Drug Screen Kit #49204
Collection Instructions for ARUP Drug Screen Kit #49204 Manufacturer Purpose of Kit / Reagent (tests) Kit / Reagent Contents (list components) Other Supplies Needed ARUP Laboratories For Point of Collection
NALCOR ENERGY ALCOHOL AND DRUG PROGRAM REQUIREMENTS FOR CONTRACTORS
NALCOR ENERGY ALCOHOL AND DRUG PROGRAM REQUIREMENTS FOR CONTRACTORS At Nalcor Energy, safety is our top priority. We take collective pride in our commitment to ensuring employees, contractors and visitors
Central Government Laboratory Department of Health and Environment
Central Government Laboratory Department of Health and Environment Overview who we are and what we do What is available and what is protocol for good science Sample collection Screening Tests Confirmation
DRUG SCREENING POLICY AND PROCEDURES Effective August 31, 2015
DRUG SCREENING POLICY AND PROCEDURES Effective August 31, 2015 The signatory parties recognize that drug abuse is an illness that creates serious problems for workers, their families, the workplace and
REACH AIR MEDICAL SERVICES SUBSTANCE ABUSE POLICY FOR APPLICANTS APPLYING FOR SAFETY-SENSITIVE POSITIONS
EFFECTIVE DATE: 06/01/2013 REACH AIR MEDICAL SERVICES SUBSTANCE ABUSE POLICY FOR APPLICANTS APPLYING FOR SAFETY-SENSITIVE POSITIONS (FOR TESTING TO BE CONDUCTED IN CALIFORNIA [excluding the City of San
Drug Testing for Criminal Justice Involved Individuals in Michigan
Drug Testing for Criminal Justice Involved Individuals in Michigan Oakland County Drug Court Professionals Barbara M. Hankey, Manager Oakland County Community Corrections Session Goals O To present the
Understanding Drug Screens & PharmCAS Drug Screening Program Overview. Suzi Arant, Senior Business Developer July 8, 2011
Understanding Drug Screens & PharmCAS Drug Screening Program Overview Suzi Arant, Senior Business Developer July 8, 2011 Presentation Overview Drug Screening in Healthcare Drug Screening Panels Drugs of
1.7.8.5 EFFECTIVE DATE: February 12, 2010, unless a later date is cited at the end of a section. [1.7.8.5 NMAC - Rp, 1.7.8.5 NMAC, 02/12/2010]
TITLE 1 CHAPTER 7 PART 8 GENERAL GOVERNMENT ADMINISTRATION STATE PERSONNEL ADMINISTRATION DRUG AND ALCOHOL ABUSE 1.7.8.1 ISSUING AGENCY: State Personnel Board. [1.7.8.1 NMAC - Rp, 1.7.8.1 NMAC, 02/12/2010]
Drug Testing Reference Tables for Drug Courts
Drug Testing Reference Tables for Drug Courts July, 2009 Page 1 TABLE I. Specimen Detection Period Advantages Disadvantages URINE SWEAT (patch) ORAL FLUID (saliva) Provides a profile of both current and
This is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics
This is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics Welcome to Mayo Medical Laboratories Hot Topics. These presentations provide short discussion
I.M.P.A.C.T. National Drug Testing and Substance Abuse Program and Guidelines
IRONWORKER MANAGEMENT PROGRESSIVE ACTION COOPERATIVE TRUST I.M.P.A.C.T. National Drug Testing and Substance Abuse Program and Guidelines Effective The processes and procedures outlined may be used as a
CERTIFICATE OF COMPLIANCE OF
CERTIFICATE OF COMPLIANCE OF Name of Contractor Company GOLDEN TRIANGLE CONTRACTOR SUBSTANCE AND ALCOHOL ABUSE PROGRAM November 2002 Edition Adopted and implemented by [Name of Contractor Company] ( Company
Drug Utilization Is On The Rise
Objectives Identify the clinical issues related to opioid prescribing for chronic pain indications Define the clinical needs and expectations of urine drug testing in pain management Address preanalytical
Frequently asked Questions
Frequently asked Questions What is hair testing? Hair testing analyzes the hair shaft, rather than body fluids like urine or saliva, to determine whether illegal drugs are present. Compared to analysis
Urine Drug Testing Methadone 101 Methadone for hospitalists
Urine Drug Testing Methadone 101 Methadone for hospitalists Dr. Patricia Mark MB, BCh LEARNING OBJECTIVES Clarify the purpose of urine drug testing Distinguish between UDT for detection of illicit drug
The potential of oral fluid as a specimen in various drug testing programs
The potential of oral fluid as a specimen in various drug testing programs *Christine Moore, Cynthia Coulter, Katherine Crompton, Warren Rodrigues, Michael Vincent, James Soares Immunalysis Corporation,
Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain (CNCP)
Appendix D: Urine Drug Testing for Monitoring Opioid Therapy i. Monitoring opioid therapy with urine drug testing (UDT) ii. UDT algorithm for monitoring opioid therapy iii. UDT clinical vignettes iv. Frequently
Appropriate Use of UDT to Improve Patient Care
Published on OpioidRisk (http://www.opioidrisk.com) Home > Urine Drug Testing Urine Drug Testing This guide provides: Download Entire Guide [1] Appropriate use of Urine Drug Testing (UDT) to improve patient
I.M.P.A.C.T. Revised. SUBSTANCE ABUSE TESTING POLICY Part I. PROCEDURE MANUAL Part II
I.M.P.A.C.T. Revised SUBSTANCE ABUSE TESTING POLICY Part I & PROCEDURE MANUAL Part II REVISED June 2011 Revised Substance Abuse Policy Part I Table of Contents I. Preface I. Statement of Policy.........
71858 Federal Register / Vol. 73, No. 228 / Tuesday, November 25, 2008 / Notices
71858 Federal Register / Vol. 73, No. 228 / Tuesday, November 25, 2008 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Mandatory Guidelines for
Employer Drug Testing Solutions
Employer Drug Testing Solutions A broad range of testing and collection options backed by a service-oriented culture that s committed to showing we re there when you need us. Choose drug testing to help
Why do employers drug test? How is drug testing conducted and how accurate is it?
Workplace Drug Testing Drug testing is one action an employer can take to determine if employees or job applicants are using drugs. It can identify evidence of recent use of alcohol, prescription drugs
Department of Health and Human Services. No. 94 May 15, 2015. Part II
Vol. 80 Friday, No. 94 May 15, 2015 Part II Department of Health and Human Services Substance Abuse and Mental Health Services Administration Mandatory Guidelines for Federal Workplace Drug Testing Programs;
Best Buy Pre-Employment Drug Testing Policy
Best Buy Pre-Employment Drug Testing Policy Purpose of Policy Best Buy (the Company), is firmly committed to ensuring a safe, healthy and efficient work environment for our employees, customers and the
Author: Leo Cangianelli, The Walsh Group, 6701 Democracy Blvd., Suite 300, Bethesda, MD 21807, U.S.A.
ROSITA II Project: "Evaluation of the Draeger 'Uplink' and Securetec 'DrugWipe 5' Oral Fluid Drug Testing Devices in Hillsborough County, Florida 2005-2006 Author: Leo Cangianelli, The Walsh Group, 6701
Generation Drug Free Workplace Policy for Contractor Personnel
Generation Drug Free Workplace Policy for Contractor Personnel Revision: 04 Date: 05-06-15 Submitted: Electronic approval pages are archived in CSR Portfolio. Contact K. Kemp for a copy. Reviewed: Reviewed:
Bermuda Hospitals Board Drug Screening Programme
Bermuda Hospitals Board Drug Screening Programme Tiana Outerbridge, Employee Health Services Manager Dr. Cathryn Siddle, Employee Health Services Physician Angela Fraser-Pitcher, Human Resources Director
PHOENIX FIRE DEPARTMENT ALCOHOL AND SUBSTANCE ABUSE EDUCATION, AWARENESS, TREATMENT & PREVENTION PROGRAM PROCESS PROCEDURE
PHOENIX FIRE DEPARTMENT ALCOHOL AND SUBSTANCE ABUSE EDUCATION, AWARENESS, TREATMENT & PREVENTION PROGRAM PROCESS PROCEDURE REMAND TO THE SUBSTANCE ABUSE PROFESSIONAL (EAP) EVALUATION BY THE SUBSTANCE ABUSE
CUT-OFF CONCENTRATIONS FOR DRUGS OF ABUSE IN SALIVA FOR DUI, DWI OR OTHER DRIVING-RELATED CRIMES
CUT-OFF CONCENTRATIONS FOR DRUGS OF ABUSE IN SALIVA FOR DUI, DWI OR OTHER DRIVING-RELATED CRIMES Vina SPIEHLER 1, Dene BALDWIN 2, Christopher HAND 2 1 DABFT, Newport Beach, United States of America 2 Cozart
EMPLOYEE DRUG SCREENING: What You Need to Know!
EMPLOYEE DRUG SCREENING: What You Need to Know! Presented by: Murray Lappe, MD Chief Medical Officer, escreen Chief Innovation Officer, Alere Presentation Content History and background of drug testing
Toxicology CPT Code Changes for 2016
Beginning January 1, 2016, CMS deleted all 2015 drug testing G codes and will continue to not recognize the AMA CPT codes for drug testing. CMS created three G codes for presumptive testing and four G
3.1. The procedure shall be applicable to all University employees.
LINCOLN UNIVERSITY Procedure: Confirmatory Testing for Substance Abuse Procedure Number: HRM 113p Effective Date: October 2008 Revisions: Review Officer: Chief Human Resources Officer 1. Purpose 1.1. It
What Does the Drug Test Tell Us
What Does the Drug Test Tell Us QUALITATIVE TOXICOLOGY TESTING for CLINICAL MANAGEMENT of the PATIENT Background The qualitative drug test is often referred to as the drug screen - a misnomer Testing performed
Making the Leap to LC/MS/MS: Enhancing and Accelerating Clinical Research and Forensic Toxicology Applications
Making the Leap to LC/MS/MS: Enhancing and Accelerating Clinical Research and Forensic Toxicology Applications Introduction The resolving power of chromatography combined with the sensitivity and selectivity
DUI in Southern Ohio MATT 2006
DUI in Southern Ohio MATT 2006 Laureen J. Marinetti, M.S., Ph.D. Chief Toxicologist Montgomery County Coroner s s Office & Miami Valley Regional Crime Lab (MVRCL) Dayton, Ohio Region The MVRCL is a regional
Drug Screens and the Medical Review Officer
Drug Screens and the Medical Review Don Bucklin Certified MRO Faculty AAMRO Medical Director US HealthWorks Why drug test? 1 Why drug screen? Prevent the hiring of employees who abuse drugs. Dissuade current
Improved Method for the Analysis of 31 Drugs of Abuse in Oral Fluid samples using the Thomson extreme FV by LC-MS/MS
htslabs.com [email protected] 800 541.4792 760 757.8080 760 757.9367 Improved Method for the Analysis of 31 Drugs of Abuse in Oral Fluid samples using the Thomson extreme FV by LC-MS/MS Nadine Koenig 2,
General Laboratory Information
General Laboratory Information 2007 Table of Contents I. Company Overview One Source Toxicology Laboratory II. One Source Toxicology Laboratory Work Flow III. SAMHSA Certification Information Certification
RANDOM DRUG AND ALCOHOL TESTING OF STUDENTS PARTICIPATING IN COMPETITIVE ACTIVITIES
Administrative Rule RANDOM DRUG AND ALCOHOL TESTING OF STUDENTS PARTICIPATING IN COMPETITIVE ACTIVITIES Code JCDAE-R Issued 06/14 Testing Coordinator The athletic director will coordinate and supervise
One Source Toxicology Laboratory, 1213 Genoa Red Bluff, Pasadena, Texas 77504
Validation of Analysis of Amphetamines, Opiates, Phencyclidine, Cocaine, and Benzoylecgonine in Oral Fluids by Liquid Chromatography Tandem Mass Spectrometry Subbarao V. Kala*, Steve E. Harris, Tom D.
Oral Fluid Drug Testing Foils Cheaters
need to Know Oral Fluid Drug Testing Foils Cheaters By Edward J. Cone, Ph.D., FTCB Johns Hopkins School of Medicine, Baltimore, MD February 2011 The ingenuity of drug abusers to avoid detection has always
BEST PRACTICES IN DRUG TESTING OF HEALTHCARE PROFESSIONALS
ENSURING COMPLIANCE: EXPLORING BEST PRACTICES IN DRUG TESTING OF HEALTHCARE PROFESSIONALS Martha E. Brown, MD Associate Medical Director, PRN and UF Associate Professor Addiction Medicine Division Disclosures
Substance Abuse Prevention Program
Planning, Design and Construction 14528 S Outer Forty Suite 100 Chesterfield, MO 63017 (314) 628-3494 (314) 628-3715 Substance Abuse Prevention Program REFERENCES: In an effort to create a safe workplace,
OU MEDICAL CENTER Human Resource Policy and Procedure Manual. Subject: Drug and Alcohol
OU MEDICAL CENTER Human Resource Policy and Procedure Manual Subject: Drug and Alcohol Section: HR 6-10 Page: 1 of 5 Origination Date: 6/2004 Revision Date: 2/2006, 9/2008, 7/2009 Coverage: All OUMC employees
Oral fluid drug tests: Effects of adulterants and foodstuffs
Forensic Science International 150 (2005) 175 180 www.elsevier.com/locate/forsciint Oral fluid drug tests: Effects of adulterants and foodstuffs Raphael C. Wong *, Minhchau Tran, James K. Tung Branan Medical
Thermo Scientific Capitol Vial Drugs of Abuse Products. The tools to create and maintain. a safe and drug free environment
Thermo Scientific Capitol Vial Drugs of Abuse Products The tools to create and maintain a safe and drug free environment Drugs of Abuse Specimen Collection We are a world leading manufacturer of Drugs
THE COLLEGE OF WESTERN IDAHO PTE PROGRAMS DRUG FREE SCHOOL POLICY
THE COLLEGE OF WESTERN IDAHO PTE PROGRAMS DRUG FREE SCHOOL POLICY Policy Statement The College of Western Idaho s PTE Programs has an interest in establishing an environment free of the influence of drugs
Clinical Drug Testing in Primary Care
Clinical Drug Testing in Primary Care Technical Assistance Publication Series TAP 32 Clinical Drug Testing in Primary Care TAP Technical Assistance Publication Series 32 U.S. DEPARTMENT OF HEALTH AND
Making the Leap to LC/MS/MS: Enhancing and Accelerating Clinical Research and Forensic Toxicology Applications
TECHNICAL NOTE Toxicology Making the Leap to LC/MS/MS: Enhancing and Accelerating Clinical Research and Forensic Toxicology Applications Introduction The resolving power of chromatography combined with
LAKE COUNTY SCHOOLS RECEIPT OF DRUG-FREE WORKPLACE POLICY
LAKE COUNTY SCHOOLS RECEIPT OF DRUG-FREE WORKPLACE POLICY I hereby acknowledge receipt of the Lake County School Board s Drug-Free Workplace Policy. I Understand that the name, address and telephone number
Drug Testing to Support Pain Management
NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of
Urine Specimen Dilution: Assessment and Policy Recommendations
Urine Specimen Dilution: Assessment and Policy Recommendations Dr. Leo Kadehjian uly 21, 2003 The following comments and recommendations are for informational use only. Consultation with program counsel
SUBSTANCE ABUSE PROGRAM
Associated Steel Erectors of Chicago and International Association of Bridge, Structural, Ornamental and Reinforcing Ironworkers Local Union #1 SUBSTANCE ABUSE PROGRAM EFFECTIVE DATE: January 1, 2007 (Revised
NORTH AMERICAN SUBSTANCE ABUSE PROGRAM (NASAP)
NORTH AMERICAN SUBSTANCE ABUSE PROGRAM (NASAP) 1.0 INTRODUCTION The Owner Members of the Houston Business Roundtable (HBR) recognize the benefits of having a safe and substance abuse-free work force. A
Queen Anne s County Fire & EMS Commission Operations Manual
I. SCOPE A. This applies to all Queen Anne s County Fire and EMS personnel. II. PURPOSE A. The purpose of this document is to establish a standardized guideline for credentialing of QAC affiliated EMS
C. The prospective employee must thoroughly read the LFCC Pre-Employment Drug
Pre-Employment Drug Screening Policy Policy No. 40001 Effective Date March 2006 Revision Date Revision No. Approved: John J. Ski Sygielski and President s Cabinet Date: March 2006 1.0 Purpose Substance
PtProtect Pain Medication Management Program Monitors Patient Compliance
PHYSICIAN UPDATE 2013 Edition PtProtect Pain Medication Management Program Monitors Patient Compliance The PtProtect (Patient Protect) program offers pain medication management panels designed to improve
ADMINISTRATIVE DIRECTIVE: 14-15 OFFENDER SUBSTANCE ABUSE. APPROVED: Signature on File EFFECTIVE: July 28, 2014
ADMINISTRATIVE DIRECTIVE: 14-15 OFFENDER SUBSTANCE ABUSE TO: FROM: ARKANSAS COMMUNITY CORRECTION EMPLOYEES SHEILA SHARP, DIRECTOR SUPERSEDES: AD 08-12 APPROVED: on File EFFECTIVE: July 28, 2014 I. APPLICABILITY.
NEW CASTLE AREA SCHOOL DISTRICT
SECTION: PUPILS No. 227.1 NEW CASTLE AREA SCHOOL DISTRICT TITLE: ADOPTED: May 12, 2004 DRUG AND ALCOHOL AWARENESS AND TESTING FOR ATHLETIC PROGRAMS, EXTRACURRICULAR ACTIVITIES, OR ACTIVITIES REVISED: June
Content Sheet 5-1: Overview of Sample Management
Content Sheet 5-1: Overview of Management Role in quality management system management is a part of process control, one of the essentials of a quality management system. The quality of the work a laboratory
Once your samples are received the only correspondence you will have with The Genetics Company is via the email address you provide.
Anonymous Infidelity DNA Test Instructions Thank you for your interest in an anonymous Infidelity DNA test. The Genetics Company guarantees to maintain your anonymity. This five page document will outline
Oral Fluid Testing: Promises and Pitfalls
Clinical Chemistry 57:6 805 810 (2011) Q&A Oral Fluid Testing: Promises and Pitfalls Moderator: Marilyn A. Huestis 1* Experts: Alain Verstraete, 2 Tai C. Kwong, 3 Jorg Morland, 4 Michael J. Vincent, 5
URINE DRUG TESTING. Effective December 1 st, 2012
URINE DRUG TESTING Effective December 1 st, 2012 Policy Neighborhood Health Plan (NHP) reimburses medically appropriate urine drug testing (UDT) to detect the parent drug and/or its metabolite(s) to demonstrate
How To Get A Standdown
TITLE 49: TRANSPORTATION Page 1 of 101 PART 40 - PROCEDURES FOR TRANSPORTATION WORKPLACE DRUG AND ALCOHOL TESTING PROGRAMS (Updated September 27, 2011) Reprinted by the Department of Transportation, Drug
How To Test For Drugs And Alcohol
PARSONS CONSTRUCTORS INC. ALCOHOL/DRUG FREE WORKPLACE POLICY 1.0 INTRODUCTION The Parsons Constructors Inc. (PCI) Drug and Alcohol-Free Workplace Policy is a standardized construction contractor substance
State of North Carolina Department of Correction Division of Prisons
State of North Carolina Department of Correction Division of Prisons POLICY AND PROCEDURE Chapter: F Section:.2600 Title: Issue Date: 06/01/10 Supersedes: 05/12/03 Inmate Drug / Alcohol Testing.2601 PURPOSE
THE DRUG AND ALCOHOL SCREENING PROGRAM
THE DRUG AND ALCOHOL SCREENING PROGRAM Revision 8- June 1 2014 Table of Contents Page Section 1 Introduction 3 Section 2 Commitment to Confidentiality 3 Section 3 Card Identification System 4 Section 4
MOSAIC DES MOINES Alcohol/Drug Free Workplace Policy
MOSAIC DES MOINES Alcohol/Drug Free Workplace Policy Purpose: To help safeguard employee health, provide a safe and productive workplace, and supply our people served with high quality service, Mosaic
Factors Influencing LC/MS/MS Moving into Clinical and Research Laboratories
Factors Influencing LC/MS/MS Moving into Clinical and Research Laboratories Matthew Clabaugh, Market Development AACC Workshop St. Louis, MO September 17,18 2013 Factors Influencing LCMSMS Moving into
1 March 2013. HUMAN RESOURCES Employee Drug Testing, Substance Abuse and Drug Free Workplace Policy POLICY Number: B-002
HUMAN RESOURCES Employee Drug Testing, Substance Abuse and Drug Free Workplace Policy POLICY Number: B-002 1. AUTHORITY: Director of State Civil Service as contained La. R.S. 36:54 2. REFERENCES: La. R.S.
Urine drug screens. Screening Methods
Screening Methods Urine drug screens Urine drug screens are generally performed using either immunoassays or gas chromatography-mass spectrometry (GC-MS). 2 Immunoassay UDS contain specific antibodies
Hair Drug & Alcohol Testing FAQs
HAIR DRUG TESTING More than DNA Hair Drug & Alcohol Testing FAQs Need advice about testing? Contact us using our online SMS service or call Cellmark free on 0800 043 4247 2045 Introduction Cellmark is
THE CONSTRUCTION INDUSTRY SUBSTANCE ABUSE PROGRAM (CISAP)
THE CONSTRUCTION INDUSTRY SUBSTANCE ABUSE PROGRAM (CISAP) As prepared by: The Construction Industry Substance Abuse Committee The purpose of the substance abuse program is to establish and maintain a drug
Asset Marketing Services, Inc. Drug and Alcohol Testing Policy (MN)
Drug and Alcohol Use Asset Marketing Services, Inc. Drug and Alcohol Testing Policy (MN) Illegal drug use in the workplace is against the law and highly detrimental to the safety and productivity of our
How To Test For Illegal Drugs And Alcohol
DRUG AND ALCOHOL TESTING POLICY Policy This policy applies to all persons who are applicants for or who are employed in positions with duties or activities that involve the requirement of a commercial
Frequently Asked Questions About Syva s EMIT Drug-Abuse Tests. Test Result Interpretation. Answers for life.
Siemens Healthcare Diagnostics, the leading clinical diagnostics company, is committed to providing clinicians with the vital information they need for the accurate diagnosis, treatment and monitoring
HEAT AND FROST INSULATORS AND ALLIED WORKERS LOCAL 45 JOINT APPRENTICESHIP AND TRAINING COMMITTEE DRUG-FREE SUBSTANCE ABUSE POLICY AND PROCEDURE
HEAT AND FROST INSULATORS AND ALLIED WORKERS LOCAL 45 JOINT APPRENTICESHIP AND TRAINING COMMITTEE I. PURPOSE DRUG-FREE SUBSTANCE ABUSE POLICY AND PROCEDURE The purpose of this Substance Abuse Policy (hereinafter
Contractor compliance with the Alcohol & Drug Program. Rigorous. Respectful. Ready.
Contractor compliance with the Alcohol & Drug Program Rigorous. Respectful. Ready. Table of contents Cenovus s commitment 1 Expectations of our contractors 2 Prevention 5 Impaired driving 6 Testing and
LC-MS for Pain Management Support. Gwen McMillin, PhD, DABCC(CC,TC) University of Utah ARUP Laboratories
LC-MS for Pain Management Support Gwen McMillin, PhD, DABCC(CC,TC) University of Utah ARUP Laboratories Outline Overview of drug testing, as a component of the therapeutic plan, in the management of chronic
The Conco Companies - Non Commercial Driver. Drug and Alcohol Policy Program
The Conco Companies - Non Commercial Driver Drug and Alcohol Policy Program 1 2 I. Purpose Statement The purpose of The Conco Companies Drug & Alcohol Policy is to create, encourage and enforce a safe
HACH COMPANY DRUG AND ALCOHOL POLICY
HACH COMPANY DRUG AND ALCOHOL POLICY I. Purpose Hach Company is committed to a safe, healthy, and productive work environment for all Associates free from the effects of substance abuse. Abuse of alcohol,
LC-MS for Pain Management Support
LC-MS for Pain Management Support Gwen McMillin, PhD, DABCC(CC,TC) University of Utah ARUP Laboratories Outline Overview of drug testing, as a component of the therapeutic plan, in the management of chronic
Alcohol and Drug Guidelines and Work Rule. A best practice guide of the Construction Owners Association of Alberta
Alcohol and Drug Guidelines and Work Rule A best practice guide of the Construction Owners Association of Alberta Version 5.0 Effective October 8, 2014 Note to readers The Canadian Model for Providing
Advantages & Disadvantages of Drug Testing in Alternative Matrices
Advantages & Disadvantages of Drug Testing in Alternative Matrices Marilyn A. Huestis, Ph.D. Chief, Chemistry & Drug Metabolism, IRP National Institute on Drug Abuse National Institutes of Health OJP Offender
